Market revenue in 2023 | USD 457.0 million |
Market revenue in 2030 | USD 937.2 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Semi-solid formulations |
Fastest growing segment | Solid Formulations |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Semi-solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products |
Key market players worldwide | The Lubrizol Corp, Piramal Pharma Solutions, Cambrex, Contract Pharmaceuticals Limited, Bora Pharmaceuticals, Ascendia Pharmaceuticals, Pierre Fabre, DPT Laboratories, MediPharm Labs Corp, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to topical drugs cdmo market will help companies and investors design strategic landscapes.
Semi-solid formulations was the largest segment with a revenue share of 67.99% in 2023. Horizon Databook has segmented the Norway topical drugs cdmo market based on semi-solid formulations, liquid formulations drugs, solid formulations, transdermal products covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway topical drugs cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Norway topical drugs cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account